OTCPK:KHRNF (Canada) Also trade in: Canada Germany

Khiron Life Sciences Corp

$ 1.67 -0.05 (-2.91%)
Volume: 67,174 Avg Vol (1m): 202,476
Market Cap $: 185.52 Mil Enterprise Value $: 156.77 Mil
P/E (TTM): 0.00 P/B: 3.48
Earnings Power Value -0.05
Net Current Asset Value 0.3
Tangible Book 0.42
Projected FCF -0.04
Median P/S Value 2.79
Graham Number 0
Peter Lynch Value 0
DCF (FCF Based) 0
DCF (Earnings Based) 0
1Y (-%)

Financial Strength : 6.6/10

GuruFocus Financial Strength Rank measures how strong a company's financial situation is . It is based on these factors
1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.
A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.
Current vs industry vs history
Cash-to-Debt 15.07
Cash-To-Debt range over the past 10 years
Min: 7.53, Med: 10000, Max: 10000
Current: 15.07
7.53
10000
Equity-to-Asset 0.76
Equity-to-Asset range over the past 10 years
Min: 0.63, Med: 0.69, Max: 0.76
Current: 0.76
0.63
0.76
Debt-to-Equity 0.05
Debt-to-Equity range over the past 10 years
Min: 0.05, Med: 0.08, Max: 0.1
Current: 0.05
0.05
0.1
Debt-to-EBITDA -0.10
Debt-to-EBITDA range over the past 10 years
Min: -0.13, Med: -0.13, Max: -0.1
Current: -0.1
-0.13
-0.1
Piotroski F-Score 5
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 7.63
DISTRESS
GREY
SAFE
WACC vs ROIC %
ROIC -562.27%
WACC 25.41%

Profitability & Growth : 4/10

GuruFocus Profitability Rank ranks how profitable a company is and how likely the company's business will stay that way.
Current vs industry vs history
Operating Margin % -905.03
Operating Margin range over the past 10 years
Min: -2230.49, Med: -2230.49, Max: -905.03
Current: -905.03
-2230.49
-905.03
Net Margin % -871.37
Net Margin range over the past 10 years
Min: -2220.52, Med: -2220.52, Max: -871.37
Current: -871.37
-2220.52
-871.37
ROE % -130.89
ROE range over the past 10 years
Min: -156.76, Med: -122.35, Max: -7.48
Current: -130.89
-156.76
-7.48
ROA % -97.39
ROA range over the past 10 years
Min: -272.73, Med: -108.62, Max: -6.84
Current: -97.39
-272.73
-6.84
ROC (Joel Greenblatt) % -526.07
ROC (Joel Greenblatt) range over the past 10 years
Min: -526.07, Med: -413.6, Max: -413.6
Current: -526.07
-526.07
-413.6
3-Year Total EBITDA Growth Rate -452.40
3-Year EBITDA Growth Rate range over the past 10 years
Min: -91.9, Med: 14.45, Max: 40.3
Current: 7.1
-91.9
40.3
3-Year EPS w/o NRI Growth Rate 4.40
3-Year EPS w/o NRI Growth Rate range over the past 10 years
Min: 0, Med: 12.5, Max: 39.4
Current: 4.4
0
39.4

» KHRNF's 30-Y Financials

Financials (Next Earnings Date: )

Guru Trades Click for details

» Details

Insider Trades

SEC Filings

Gurus Latest Trades with OTCPK:KHRNF

» Interactive Chart

Peter Lynch Chart

Business Description

Industry Drug Manufacturers » Drug Manufacturers    NAICS : 325412    SIC : 3741
Compare ROCO:4114 XMAD:RJF OSTO:CALTX NAS:ADMS MIL:PHN XKRX:072020 TSXV:RIV HKSE:03737 TSXV:VIVO XKRX:006620 TSE:4538 HKSE:01011 TSE:4597 TSXV:WMD DHA:ACI XTER:93M XKLS:7081 NAS:GALT ROCO:6550 XKRX:175250
Traded in other countries KHRN.Canada 4KH.Germany
Address 2300 - 500 Burrard Street, Vancouver, BC, CAN, V6C 2B5
Adent Capital Corp is a capital pool company. It is engaged in the business of identification and evaluation of assets or businesses with a view to a completing a qualifying transaction.

Ratios

Current vs industry vs history
PB Ratio 3.48
PB Ratio range over the past 10 years
Min: 2.82, Med: 5.04, Max: 11.16
Current: 3.48
2.82
11.16
PS Ratio 53.37
PS Ratio range over the past 10 years
Min: 43.13, Med: 89.39, Max: 311.54
Current: 53.37
43.13
311.54
EV-to-EBIT -6.82
EV-to-EBIT range over the past 10 years
Min: -12.8, Med: -7.55, Max: -3.5
Current: -6.82
-12.8
-3.5
EV-to-EBITDA -7.00
EV-to-EBITDA range over the past 10 years
Min: -13, Med: -7.7, Max: -3.6
Current: -7
-13
-3.6
EV-to-Revenue 62.23
EV-to-Revenue range over the past 10 years
Min: 46, Med: 81.2, Max: 301.5
Current: 62.23
46
301.5
Current Ratio 4.74
Current Ratio range over the past 10 years
Min: 0.05, Med: 2.75, Max: 11.92
Current: 4.74
0.05
11.92
Quick Ratio 4.71
Quick Ratio range over the past 10 years
Min: 0.05, Med: 2.75, Max: 11.92
Current: 4.71
0.05
11.92
Days Inventory 22.54
Days Inventory range over the past 10 years
Min: 22.54, Med: 73.12, Max: 73.12
Current: 22.54
22.54
73.12
Days Sales Outstanding 641.78
Days Sales Outstanding range over the past 10 years
Min: 641.78, Med: 1706.74, Max: 1706.74
Current: 641.78
641.78
1706.74
Days Payable 1.00
Days Payable range over the past 10 years
Min: 1, Med: 3679.49, Max: 3679.49
Current: 1
1
3679.49

Dividend & Buy Back

Current vs industry vs history
3-Year Share Buyback Rate -534.40
3-Year Share Buyback Rate range over the past 10 years
Min: -534.4, Med: -5.3, Max: 8.7
Current: -534.4
-534.4
8.7

Valuation & Return

Current vs industry vs history
Price-to-Tangible-Book 3.98
Price-to-Tangible-Book range over the past 10 years
Min: 0.74, Med: 5.26, Max: 23.08
Current: 3.98
0.74
23.08
Price-to-Median-PS-Value 0.60
Price-to-Median-PS-Value range over the past 10 years
Min: 0.48, Med: 1.19, Max: 1.31
Current: 0.6
0.48
1.31
Earnings Yield (Joel Greenblatt) % -14.56
Earnings Yield (Greenblatt) range over the past 10 years
Min: -28.5, Med: -13.2, Max: -7.8
Current: -14.56
-28.5
-7.8

More Statistics

Revenue (TTM) (Mil) $ 2.23
EPS (TTM) $ -0.36
Beta 0
Volatility % 140.76
52-Week Range $ 0.66 - 3.28
Shares Outstanding (Mil) 110.44

Analyst Estimate

Piotroski F-Score Details

Piotroski F-Score 5
Positive ROA N
Positive CFROA N
Higher ROA yoy Y
CFROA > ROA Y
Lower Leverage yoy N
Higher Current Ratio yoy Y
Less Shares Outstanding yoy N
Higher Gross Margin yoy Y
Higher Asset Turnover yoy Y